EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Vitiligo-Like Hypopigmentation Induced by Ribociclib in a Patient With Metastatic Breast Cancer

Israe El Ghazouli, Salim Gallouj, Ouiame El Jouari

Cureus · 18.05.2026

DOI: 10.7759/cureus.109083 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 18.05.2026. Verfasst von Israe El Ghazouli und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Faculty of Medicine and Pharmacy, Abdelmalek Essaadi University, University Hospital Mohammed VI, Tangier, MAR. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

cdk4/6 inhibitorscheckpoint inhibitorsribociclibskin toxicitiesvitiligo-like

Autor:innen und Institutionen

  • Dermatology Department, Faculty of Medicine and Pharmacy, Abdelmalek Essaadi University, University Hospital Mohammed VI, Tangier, MAR.

Zitieren

APA

El Ghazouli, I., Gallouj, S., & El Jouari, O. (2026). Vitiligo-Like Hypopigmentation Induced by Ribociclib in a Patient With Metastatic Breast Cancer. Cureus. https://doi.org/10.7759/cureus.109083

Vancouver

El Ghazouli I, Gallouj S, El Jouari O. Vitiligo-Like Hypopigmentation Induced by Ribociclib in a Patient With Metastatic Breast Cancer. Cureus. 2026. doi:10.7759/cureus.109083

BibTeX
@article{ElGhazouli2026,
  author = {El Ghazouli, Israe and Gallouj, Salim and El Jouari, Ouiame},
  title = {Vitiligo-Like Hypopigmentation Induced by Ribociclib in a Patient With Metastatic Breast Cancer},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.109083}
}
Kostenlos starten →